Prognostic Factors of Survival in Glioblastoma Multiforme Patients—A Retrospective Study

Abstract

Background: Glioblastoma multiforme (GBM) is the most aggressive brain tumor that occurs in adults. In spite of prompt diagnosis and rapidly administered treatment, the survival expectancy is tremendously poor. Extensive research has been performed in order to establish factors to predict the outcome of GBM patients; however, worldwide accepted prognostic markers are still lacking. Methods: We retrospectively assessed all adult patients who were diagnosed with primary GBM and underwent surgical treatment during a three-year period (January 2017–December 2019) in the Neurosurgery Department of the Emergency Clinical County Hospital of Târgu Mureș, Romania. Our aim was to find any statistically relevant connections between clinical, imagistic, and histopathological characteristics and patients’ survival. Results: A total of 75 patients were eventually included in our statistical analysis: 40 males and 35 females, with a median age of 61 years. The mean tumor dimension was 45.28 ± 15.52 mm, while the mean survival rate was 4 ± 6.75 months. A univariate analysis demonstrated a statistically significant impact of tumor size, pre-, and postoperative KPSI on survival rate. In addition, a Cox multivariate assessment strengthened previous findings regarding postoperative KPSI (regression coefficient −0.03, HR 0.97, 95% CI (HR) 0.96–0.99, p = 0.002) as a favorable prognostic factor and GBM size (regression coefficient 0.03, HR 1.03, 95% CI (HR) 1.01–1.05, p = 0.005) as a poor prognostic marker for patients’ survival. Conclusions: The results of our retrospective study are consistent with prior scientific results that provide evidence supporting the importance of clinical (quantified by KPSI) and imagistic (particularly tumor dimensions) features as reliable prognostic factors in GBM patients’ survival.

Preoperative Immune-Inflammatory Status of the Patients With Newly-Diagnosed Glioblastoma – Could It Genuinely Predict Their Survival?

“…Furthermore, we found a weak positive association between tumor size and NLR levels. A previous study on a similar cohort demonstrated that the GBM dimension is an unfavorable prognostic marker for patients' survival [ 18 ]. This implies that NLR might carry a prognostic significance, although no statistically significant conclusion can be drawn to support it.…”

Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells

“…Glioblastoma multiform (GBM) is the most common malignant adult brain cancer, characterized by a poor prognosis (approximately 15 months after diagnosis) [ 1 , 2 , 3 ]. According to the World Health Organization (WHO) classification, it is considered a grade IV glioma.…”

Impact of age and gender on survival of glioblastoma multiforme patients: A multicentric retrospective study

“…Furthermore, studies have shown that distinct histopathological subtypes exhibit different treatment responses, resulting in varying survival rates. In addition to patient age and sex, predictive factors include clinical parameters, the extent of surgical resection, and tumor imaging characteristics, including tumor size, location, the presence of necrosis, and surrounding edema 13 . The primary treatment involves comprehensive surgical removal while preserving neurological function and minimizing postoperative complications.…”